Stock Research: ICON

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

ICON

NasdaqGS:ICLR IE0005711209
6
  • Value
    49
  • Growth
    3
  • Safety
    Safety
    45
  • Combined
    4
  • Sentiment
    13
  • 360° View
    360° View
    6
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

ICON Public Limited Company is a healthcare intelligence and clinical research organization providing outsourced services to pharmaceutical, biotechnology, and medical device companies. It operates across sectors like biosimilars, medical devices, and pharmaceuticals. In the last fiscal year, the company had a market cap of $11657 million, profits of $2444 million, revenue of $8282 million, and 41900 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 6 (better than 6% compared with alternatives), overall professional sentiment and financial characteristics for the stock ICON are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for ICON. The consolidated Value Rank has a low rank of 45 which means that the share price of ICON is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 55% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 3, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 3% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 49, which means that the company has a riskier financing structure than 51% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 13, which means that professional investors are more pessimistic about the stock than for 87% of alternative investment opportunities. ...read more

more
Index
Employee Health EU
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
45 30 19 33
Growth
3 30 95 97
Safety
Safety
49 34 14 82
Sentiment
13 45 63 38
360° View
360° View
6 9 50 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
48 74 68 49
Opinions Change
18 52 75 42
Pro Holdings
n/a n/a n/a n/a
Market Pulse
24 25 30 38
Sentiment
13 45 63 38
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
45 30 19 33
Growth
3 30 95 97
Safety Safety
49 34 14 82
Combined
4 6 34 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
50 38 28 25
Price vs. Earnings (P/E)
47 53 38 39
Price vs. Book (P/B)
66 58 34 65
Dividend Yield
1 1 1 1
Value
45 30 19 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
8 18 62 88
Profit Growth
14 60 70 70
Capital Growth
41 73 73 93
Stock Returns
7 12 91 81
Growth
3 30 95 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
54 59 46 74
Refinancing
47 40 25 35
Liquidity
27 26 16 73
Safety Safety
49 34 14 82

Similar Stocks

Discover high‑ranked alternatives to ICON and broaden your portfolio horizons.

Perrigo

NYSE:PRGO
Country: Ireland
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Continental

XTRA:CON
Country: Germany
Industry: Auto Parts & Equipment
Size: X-Large
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.